Glyn Edwards, Chief Executive Officer

Mr Glyn Edwards was appointed to the Board of Directors as Chief Executive Officer in April 2012.  Mr Edwards has a wealth of experience garnered from a thirty-year career in the life sciences industry, during which time he has held a number of senior executive and business development roles.  Prior to joining Summit, he was interim Chief Executive Officer of the UK trade body the BioIndustry Association (BIA) and Chief Executive Officer at Antisoma plc for 13 years, and Vice President of Business Development at Therapeutic Antibodies Ltd.  Mr Edwards holds a BSc in Biochemistry from Bristol University and an MSc in Economics from the London Business School.


Erik Ostrowski, Chief Financial Officer

Mr Erik Ostrowski was appointed as our Chief Financial Officer in June 2014.  Prior to joining Summit Mr Ostrowski served as Vice President of Finance at Organogenesis Inc., a biotechnology company, from 2010 to 2014.  Prior to that, Mr Ostrowski worked in investment banking, most recently as a Director with Leerink Partners LLC.  Mr Ostrowski began his career as an accountant with Coopers & Lybrand.  Mr Ostrowski received a Bachelors of Science in Accounting and Economics from Babson College and an MBA from the University of Chicago Booth School of Business.